查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494747

到 2030 年兽医保健市场预测：按产品、疾病、最终用户和地区进行的全球分析

Veterinary Healthcare Market Forecasts to 2030 - Global Analysis By Product, Disease, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球兽医保健市场规模为 460.7 亿美元，预计预测期内复合年增长率为 11.11%，到 2030 年将达到 866.9 亿美元。

兽医保健涵盖频谱的医疗服务，旨在促进动物的福祉和健康。包括针对各种动物物种（包括宠物、牲畜、野生动物和异国风动物）的预防措施、诊断、治疗和復原。兽医透过其在外科、内科、牙科、营养、行为等方面的专业知识，在保护动物福利、公共卫生和环境方面发挥重要作用。其职责不仅限于照顾个别动物，还包括疾病控制、疫苗接种计划以及旨在推进医学知识和改善医疗保健结果的研究。

根据美国宠物产品协会的数据，兽医支出正在稳步增长，2021 年美国消费者在兽医护理和产品销售上的支出为 1,236 亿美元。

宠物保险增加

随着越来越多的人购买宠物保险，即使在非紧急情况下也越来越希望去看兽医。这项变更减少了可能阻碍饲主为其动物接受预防性和定期治疗的经济障碍。因此，兽医可以增加患者数量，投资先进的设备、设施和培训，并提高整体护理品质。此外，保险范围鼓励饲主遵守治疗计划和后续观察预约，从而改善宠物的健康状况。

景气衰退

景气衰退可能对兽医保健市场产生重大影响。在经济状况，宠物饲主可能会削减非必要开支，包括兽医护理、选择更便宜的替代疗法或推迟定期就诊。因此，对兽医服务和产品的需求将减少，最终影响兽医院和製药公司的收益。然而，由于经济不确定性，消费者推迟或放弃购买新宠物，需求可能会进一步下降。

动物医学的进展

MRI 和电脑断层扫描等先进影像技术等创新技术可以更准确地诊断动物的复杂疾病状况。药物开发提供了更有效、副作用更少的药物，改善了动物的治疗结果和生活品质。此外，微创手术技术透过减少恢復时间和术后併发症进一步推动兽医学的发展。整合远端医疗可以实现远端咨询和监控，改善兽医服务的获取，特别是在服务不足的地区。

兽医短缺

提供护理的专业人员数量的减少将增加现有兽医的负担，增加预约的等待时间，减少获得兽医服务的机会，并使从业人员更加忙碌，提供护理的能力可能会下降。然而，兽医短缺也限制了兽医诊所向服务不足地区的扩张，加剧了伴同性动物和牲畜获得医疗保健的不平等。缺乏能够推动研究和实施进步的专家限制了该领域创新疗法和技术的开发和实施。

COVID-19 的影响：

COVID-19 大流行对兽医保健市场产生了重大影响。我们看到宠物饲主的行为发生了显着变化，许多人花更多时间待在家里，锁上门，并且更加关注宠物的健康和福祉。宠物拥有量的迅速增加以及对宠物健康的关注导致对预防保健、疫苗接种和远端医疗咨询等兽医服务的需求增加。然而，法规和安全措施暂时关闭了一些兽医诊所并减少了亲自就诊，影响了常规和非紧急护理。

预计过敏领域在预测期内将是最大的。

预计过敏领域在预测期内将是最大的。随着全球宠物数量的增加，人们对宠物健康问题（包括过敏）的认识也随之提高。这种认识导致了对专用针对宠物的过敏治疗、诊断和低过敏产品的研发投资的增加。兽医医院正在扩大服务范围，包括过敏测试和治疗选择，吸引了为毛茸茸的同伴寻求全面护理的饲主。此外，製药公司正在推出针对宠物过敏的新药和疫苗，进一步推动市场成长。

预计兽医医院产业在预测期内的复合年增长率最高。

兽医医院部门预计在预测期内将出现最高的复合年增长率，因为它为各种动物物种（包括宠物、牲畜和异国风动物）提供广泛的专业药品、补充品和其他保健产品。透过专注于动物用药品，这些药房确保获得传统人类药房可能无法轻易获得的重要药物。此外，兽医药房通常僱用具有动物健康专业知识的员工，他们可以为宠物饲主和牲畜生产者提供个人化的指导和建议。

比最大的地区

北美地区将成为整个估计期间最大的市场占有率。兽医医院的区域扩张不仅改善了动物获得优质医疗保健的机会，而且促进了兽医医学的创新。这些医院注重预防性护理、早期发现和先进治疗，为该地区的兽医护理制定了标准。

复合年增长率最高的地区：

透过确保动物用药品和服务的安全性、有效性和质量，预计亚太地区将在预测期内实现有益增长。政府法规通常包括动物用药品和保健产品的註册、生产、分销和销售指南。透过执行严格的监管标准，政府提高了产业内的透明度和课责，并增强了全部区域消费者和相关人员的信心。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第四章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球兽医保健市场：依产品

  • 治疗药物/药品
  • 诊断工具
  • 其他产品

第六章全球兽医保健市场：依疾病分类

  • 消化系统疾病
  • 过敏
  • 关节炎

第七章 全球兽医保健市场：依最终使用者分类

  • 兽医药房
  • 兽医院
  • 其他最终用户

第八章全球兽医保健市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Zoetis Animal Healthcare
  • Ceva Animal Health Inc
  • Elanco Animal Health
  • Phibro Animal Health
  • Boehringer Ingelheim International GmbH
  • SeQuent Scientific Ltd
  • Cargill Inc
  • MSD Animal Health
  • Sanofi-Aventis
  • Bayer Healthcare
  • Novartis International AG
Product Code: SMRC26262

According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $46.07 billion in 2024 and is expected to reach $86.69 billion by 2030 growing at a CAGR of 11.11% during the forecast period. Veterinary healthcare encompasses a broad spectrum of medical services aimed at promoting the well-being and health of animals. It involves preventive measures, diagnostics, treatment, and rehabilitation for various animal species, including pets, livestock, wildlife, and exotic animals. Veterinarians play a crucial role in safeguarding animal welfare, public health, and the environment through their expertise in areas such as surgery, internal medicine, dentistry, nutrition, and behavior. Their responsibilities extend beyond individual animal care to disease control, vaccination programs, and research aimed at advancing medical knowledge and improving healthcare outcomes.

According to the American Pet Products Association, veterinary care spending has been steadily rising, with U.S. consumers spent US$ 123.6 billion in 2021 on veterinarian care and product sales.

Market Dynamics:

Driver:

Rise in pet insurance coverage

With more individuals opting for pet insurance plans, there's an increased willingness to seek veterinary care, even for non-emergency situations. This shift reduces financial barriers that might otherwise deter pet owners from seeking preventive or routine medical attention for their animals. Consequently, veterinarians experience higher patient volumes, enabling them to invest in advanced equipment, facilities, and training, thereby elevating the overall quality of care. Moreover, insurance coverage incentivizes pet owners to adhere to treatment plans and follow-up appointments, leading to better health outcomes for their pets.

Restraint:

Economic downturns

Economic downturns can significantly impact the veterinary healthcare market. During tough economic times, pet owners may cut back on non-essential expenditures, including veterinary care, opting for cheaper alternatives or delaying routine visits. This leads to reduced demand for veterinary services and products, ultimately affecting the revenue streams of veterinary clinics and pharmaceutical companies. However, economic uncertainty may prompt consumers to postpone or forego adopting new pets, further dampening demand.

Opportunity:

Advancements in veterinary medicine

Innovations such as advanced imaging technologies like MRI and CT scans enable more accurate diagnoses of complex conditions in animals. Developments in pharmaceuticals have led to the availability of more effective medications with fewer side effects, improving treatment outcomes and quality of life for animals. Moreover, minimally invasive surgical techniques have reduced recovery times and post-operative complications, further advancing veterinary care. The integration of telemedicine allows for remote consultations and monitoring, increasing accessibility to veterinary services, particularly in underserved areas.

Threat:

Shortage of veterinarians

With fewer professionals available to provide care, there's an increased burden on existing veterinarians, leading to longer wait times for appointments, reduced accessibility to veterinary services, and potentially compromised quality of care due to overwhelmed practitioners. However, this shortage also limits the expansion of veterinary practices into underserved areas, exacerbating disparities in access to healthcare for both companion animals and livestock. It restricts the development and adoption of innovative treatments and technologies within the field, as there are fewer experts available to drive research and implement advancements.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the veterinary healthcare market as there was a noticeable shift in pet owner behavior, with many people spending more time at home during lockdowns, leading to increased attention to their pets' health and well-being. This surge in pet ownership and concern for pet health translated into higher demand for veterinary services, including preventive care, vaccinations, and telemedicine consultations. However, on the flip side, restrictions and safety measures also led to temporary closures of some veterinary clinics and reduced in-person visits, affecting routine procedures and non-urgent care.

The Allergies segment is expected to be the largest during the forecast period

Allergies segment is expected to be the largest during the forecast period. As pet ownership rises globally, so does awareness of pet health issues, including allergies. This awareness has led to increased investment in research and development of allergy treatments, diagnostics, and hypoallergenic products tailored specifically for pets. Veterinary clinics are expanding their services to include allergy testing and treatment options, attracting pet owners seeking comprehensive care for their furry companions. Moreover, pharmaceutical companies are introducing new medications and vaccines targeting pet allergies, further fueling market growth.

The Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period

Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period as these pharmacies offer a wide range of medications, supplements, and other healthcare products specifically formulated for various species, including pets, livestock, and exotic animals. By focusing solely on veterinary medications, these pharmacies ensure the availability of essential drugs that may not be readily accessible in traditional human pharmacies. Moreover, veterinary pharmacies often employ staff with expertise in animal health, enabling them to offer personalized guidance and advice to pet owners and livestock producers.

Region with largest share:

North America region is poised to hold the largest market share throughout the estimated period of time as these increasing investments in veterinary hospitals are leading to the establishment of state-of-the-art facilities equipped with advanced diagnostic tools, treatment options, and specialized care services for pets. The regional expansion of veterinary hospitals is not only improving access to quality healthcare for animals but also driving innovation in veterinary medicine. With a focus on preventive care, early detection, and advanced treatments, these hospitals are raising the standard of veterinary healthcare in the region.

Region with highest CAGR:

Asia Pacific region is estimated to gain profitable growth over the extrapolated period by ensuring the safety, efficacy, and quality of veterinary products and services. Government regulations often include guidelines for the registration, manufacturing, distribution, and marketing of veterinary medicines and healthcare products. By enforcing stringent regulatory standards, governments promote transparency and accountability within the industry, fostering trust among consumers and stakeholders across the region.

Key players in the market

Some of the key players in Veterinary Healthcare market include Zoetis Animal Healthcare, Ceva Animal Health Inc, Elanco Animal Health, Phibro Animal Health, Boehringer Ingelheim International GmbH, SeQuent Scientific Ltd, Cargill Inc, MSD Animal Health, Sanofi-Aventis, Bayer Healthcare and Novartis International AG.

Key Developments:

In September 2022, Merck Animal Health announced the new label indication for both Bravectoand BravectoPlus for topical use in cats to treat and control Asian long-horned tick infestations. Bravectoand BravectoPlus for cats is the first and only U.S. product labeled for treatment and control.

In January 2022, Zoetis announced that the U.S. Food and Drug Administration (FDA) had approved a new label indication for SimparicaTrio (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks). SimparicaTrio is approved for dogs eight weeks of age and older.

Products Covered:

  • Therapeutics/Drugs
  • Diagnostic Tool
  • Other Products

Diseases Covered:

  • Gastrointestinal Diseases
  • Allergies
  • Arthritis

End Users Covered:

  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary Healthcare Market, By Product

  • 5.1 Introduction
  • 5.2 Therapeutics/Drugs
  • 5.3 Diagnostic Tool
  • 5.4 Other Products

6 Global Veterinary Healthcare Market, By Disease

  • 6.1 Introduction
  • 6.2 Gastrointestinal Diseases
  • 6.3 Allergies
  • 6.4 Arthritis

7 Global Veterinary Healthcare Market, By End User

  • 7.1 Introduction
  • 7.2 Veterinary Pharmacies
  • 7.3 Veterinary Hospitals
  • 7.4 Other End Users

8 Global Veterinary Healthcare Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Zoetis Animal Healthcare
  • 10.2 Ceva Animal Health Inc
  • 10.3 Elanco Animal Health
  • 10.4 Phibro Animal Health
  • 10.5 Boehringer Ingelheim International GmbH
  • 10.6 SeQuent Scientific Ltd
  • 10.7 Cargill Inc
  • 10.8 MSD Animal Health
  • 10.9 Sanofi-Aventis
  • 10.10 Bayer Healthcare
  • 10.11 Novartis International AG

List of Tables

  • Table 1 Global Veterinary Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 4 Global Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 5 Global Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 6 Global Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 7 Global Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 8 Global Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 9 Global Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 10 Global Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 11 Global Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 12 Global Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 13 Global Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 14 North America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 15 North America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 16 North America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 17 North America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 18 North America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 19 North America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 20 North America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 21 North America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 22 North America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 23 North America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 North America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 25 North America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 26 North America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 27 Europe Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 28 Europe Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 29 Europe Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 30 Europe Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 31 Europe Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 32 Europe Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 33 Europe Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 34 Europe Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 35 Europe Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 36 Europe Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 37 Europe Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 38 Europe Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 39 Europe Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 40 Asia Pacific Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 41 Asia Pacific Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 42 Asia Pacific Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 43 Asia Pacific Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 44 Asia Pacific Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 45 Asia Pacific Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 46 Asia Pacific Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 47 Asia Pacific Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 48 Asia Pacific Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 49 Asia Pacific Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 50 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 51 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 52 Asia Pacific Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 53 South America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 54 South America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 55 South America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 56 South America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 57 South America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 58 South America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 59 South America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 60 South America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 61 South America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 62 South America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 63 South America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 64 South America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 65 South America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 66 Middle East & Africa Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 67 Middle East & Africa Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 68 Middle East & Africa Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 69 Middle East & Africa Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 70 Middle East & Africa Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 71 Middle East & Africa Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 72 Middle East & Africa Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 73 Middle East & Africa Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 74 Middle East & Africa Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 75 Middle East & Africa Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 76 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 77 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 78 Middle East & Africa Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)